Benardais Karelle, Ornelas Isis M, Fauveau Melissa, Brown Tanya L, Finseth Lisbet T, Panic Radmila, Deboux Cyrille, Macklin Wendy B, Wood Teresa L, Nait-Oumesmar Brahim
Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, Hôpital de la Pitié-Salpêtrière, Paris, France.
Department of Pharmacology, Physiology & Neuroscience, New Jersey Medical School, Rutgers University, Newark, NJ 07101, USA.
Brain Commun. 2022 Feb 12;4(1):fcac025. doi: 10.1093/braincomms/fcac025. eCollection 2022.
The p70 ribosomal S6 kinases (p70 ribosomal S6 kinase 1 and p70 ribosomal S6 kinase 2) are downstream targets of the mechanistic target of rapamycin signalling pathway. p70 ribosomal S6 kinase 1 specifically has demonstrated functions in regulating cell size in and in insulin-sensitive cell populations in mammals. Prior studies demonstrated that the mechanistic target of the rapamycin pathway promotes oligodendrocyte differentiation and developmental myelination; however, how the immediate downstream targets of mechanistic target of rapamycin regulate these processes has not been elucidated. Here, we tested the hypothesis that p70 ribosomal S6 kinase 1 regulates oligodendrocyte differentiation during developmental myelination and remyelination processes in the CNS. We demonstrate that p70 ribosomal S6 kinase activity peaks in oligodendrocyte lineage cells at the time when they transition to myelinating oligodendrocytes during developmental myelination in the mouse spinal cord. We further show p70 ribosomal S6 kinase activity in differentiating oligodendrocytes in acute demyelinating lesions induced by lysophosphatidylcholine injection or by experimental autoimmune encephalomyelitis in mice. In demyelinated lesions, the expression of the p70 ribosomal S6 kinase target, phosphorylated S6 ribosomal protein, was transient and highest in maturing oligodendrocytes. Interestingly, we also identified p70 ribosomal S6 kinase activity in oligodendrocyte lineage cells in active multiple sclerosis lesions. Consistent with its predicted function in promoting oligodendrocyte differentiation, we demonstrate that specifically inhibiting p70 ribosomal S6 kinase 1 in cultured oligodendrocyte precursor cells significantly impairs cell lineage progression and expression of myelin basic protein. Finally, we used zebrafish to show that inhibiting p70 ribosomal S6 kinase 1 function in oligodendroglial cells reduces their differentiation and the number of myelin internodes produced. These data reveal an essential function of p70 ribosomal S6 kinase 1 in promoting oligodendrocyte differentiation during development and remyelination across multiple species.
p70核糖体S6激酶(p70核糖体S6激酶1和p70核糖体S6激酶2)是雷帕霉素作用机制信号通路的下游靶点。p70核糖体S6激酶1在调节哺乳动物中特定细胞群以及胰岛素敏感细胞群的细胞大小方面具有明确的功能。先前的研究表明,雷帕霉素作用机制信号通路可促进少突胶质细胞分化和发育性髓鞘形成;然而,雷帕霉素作用机制信号通路的直接下游靶点如何调节这些过程尚未阐明。在此,我们检验了这样一个假设,即p70核糖体S6激酶1在中枢神经系统发育性髓鞘形成和再髓鞘化过程中调节少突胶质细胞分化。我们证明,在小鼠脊髓发育性髓鞘形成过程中,当少突胶质细胞系细胞转变为髓鞘形成少突胶质细胞时,p70核糖体S6激酶活性在这些细胞中达到峰值。我们进一步显示,在由溶血磷脂酰胆碱注射或实验性自身免疫性脑脊髓炎诱导的急性脱髓鞘病变中,分化中的少突胶质细胞具有p70核糖体S6激酶活性。在脱髓鞘病变中,p70核糖体S6激酶的靶点——磷酸化S6核糖体蛋白的表达是短暂的,且在成熟少突胶质细胞中最高。有趣的是,我们还在活动性多发性硬化病变的少突胶质细胞系细胞中鉴定出了p70核糖体S6激酶活性。与其促进少突胶质细胞分化的预测功能一致,我们证明,在培养的少突胶质细胞前体细胞中特异性抑制p70核糖体S6激酶可显著损害细胞系进展和髓鞘碱性蛋白的表达。最后,我们利用斑马鱼表明,抑制少突胶质细胞中p70核糖体S6激酶的功能会降低其分化以及所产生的髓鞘节段数量。这些数据揭示了p70核糖体S6激酶在多个物种的发育和再髓鞘化过程中促进少突胶质细胞分化的重要功能。